gene 1,507 words KG: ABCD2 2026-03-27
kind:genesection:genestopic:alzheimerstopic:parkinsonsstate:published
Contents

ABCD2 — ATP Binding Cassette Subfamily D Member 2

🧬 Gene Info
Gene SymbolABCD2
Full NameATP Binding Cassette Subfamily D Member 2
Chromosome12q12
Protein TypeTransporter
Functionis a peroxisomal ATP-binding cassette transporter primarily involved in the import of very long-chain fatty acids (VLCFAs) and branched-chain fatty acids into peroxisomes for beta-oxidation[@berger...
Primary Expressionbrain white matter, liver, and adrenal glands
Amino Acids706 aa
Ensembl IDENSG00000173208
GeneCardsABCD2
Human Protein AtlasABCD2
Substrate specificityTransports CoA-activated VLCFAs including hexacosanoic acid (C26:0) and lignoceric acid (C24:0)
Physiological importanceVLCFAs are essential components of myelin lipids (approximately 30% of myelin lipid mass)
Beta-oxidationImported VLCFAs undergo peroxisomal beta-oxidation to generate medium-chain acetyl-CoA
Partial compensationABCD2 can partially compensate for ABCD1 deficiency, which explains why complete loss of ABCD1 alone does not always cause severe disease
Therapeutic implicationsUpregulating ABCD2 expression has been explored as a strategy for X-ALD treatment[@kemp2011]
Associated DiseasesAls, Ms
InteractionsCLDN5, MMP9, MYC, INFLAMMATION, OXIDATIVE STRESS, BLOOD-BRAIN BARRIER DYSFUNCTION
KG Connections32 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (2)

Oligodendrocyte White Matter Vulnerability
Score: 0.40
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.37

Related Analyses (4)

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed

Related Experiments (6)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Synaptic Mitochondrial Resilience Enhancement for Parkinson'
validation · proposed · Score: 0.46
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.46
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.46
Peroxisomal Dysfunction Validation in Parkinson's Disease
validation · proposed · Score: 0.46

See Also (6)

Packard Center for ALS Research
institution · KG edge: activates
NR1H3 - Nuclear Receptor Subfamily 1 Group H Member 3
gene · KG edge: expressed_in
MYC Gene
gene · KG edge: activates
MMP9 Gene
gene · KG edge: activates
CLDN5 — Claudin-5
gene · KG edge: activates

Knowledge Graph (12 edges)

ABCD2 expressed_in NR1H3
ABCD2 associated_with ABCD1
ABCD2 expressed_in ABCD1
ABCD2 activates CLDN5
ABCD2 activates MMP9
ABCD2 activates MYC
ABCD2 activates Als
ABCD2 therapeutic_target Als
ABCD2 therapeutic_target Proteasome
ABCD2 expressed_in INFLAMMATION